荷兰全国研究:非低级别和深部软组织肉瘤在高容量医院手术后生存率提高
该荷兰全国性研究纳入2006至2015年5282例原发软组织肉瘤手术患者,按医院年手术量分为低容量(1-9例)、中容量(10-19例)和高容量(≥20例)。整体高容量医院手术无生存获益,但非低级别且深部肿瘤患者在高容量医院10年生存率54%,低容量49%,中容量42%,高容量较低容量相对风险1.3(p=0.03),作者认为此类患者应转诊至高容量医院。
要点
- 2006至2015年荷兰原发软组织肉瘤手术患者中,42%在低容量医院、7.7%在中容量医院、51%在高容量医院治疗。
- 整体队列高容量医院无生存获益,10年净生存率低容量76%、中容量68%、高容量68%。
- 非低级别且深部肿瘤亚组高容量医院10年生存率54%,低容量49%,中容量42%,相对风险1.3(高容量 vs 低容量,p=0.03)。
核心结论
- 过去十年软组织肉瘤手术的集中化程度增加,高容量医院手术改善了非低级别和深部肿瘤患者的生存,因此这些患者应转诊至此类医院。
研究设计与样本
- 荷兰全国性研究,数据来自荷兰癌症登记处,纳入2006至2015年接受原发软组织肉瘤手术的患者5282例。
- 医院按年手术量分为低容量(1-9例)、中容量(10-19例)和高容量(≥20例)三类,比较肿瘤特征和结局差异,并进行多变量回归分析校正病例组合。
主要发现
- 5282例患者中,42%在低容量医院治疗,7.7%在中容量医院治疗,51%在高容量医院治疗,随时间推移在高容量医院治疗的趋势显著(p < 0.01)。
- 高容量医院较低容量医院更多治疗非低级别、大肿瘤和深部肿瘤患者。
- 整体队列中高容量医院无生存获益,10年净生存率低容量76%、中容量68%、高容量68%。
- 非低级别且深部肿瘤亚组中,高容量医院10年生存率54%,低容量49%,中容量42%,高容量 vs 低容量相对风险1.3(p = 0.03)。
临床怎么用
- 作者认为,非低级别和深部软组织肉瘤患者应转诊至高容量医院接受手术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diagnosing and treating soft tissue sarcomas (STSs) remains challenging, stressing the urgency for centralisation. This nationwide survey aimed to evaluate the centralisation of STS surgery and its effect on survival. METHODS: Patients operated for primary STS from 2006 to 2015 were queried from the Netherlands Cancer Registry. Hospitals in which STS surgery was performed were allocated into three categories: low-volume (1-9 resections per year), medium-volume (10-19 resections) or high-volume (≥20 resections). Differences in tumour characteristics and outcome were calculated. A multivariable regression analysis was performed to adjust for case-mix. RESULTS: Of the 5282 identified patients, 42% was treated in low-volume hospitals, 7.7% in medium-volume hospitals and 51% in high-volume hospitals, with a significant trend over time towards treatment in a high-volume hospital (p < 0.01). In high-volume hospitals, more often patients with non low-grade, large and deep-seated tumours were treated than in low-volume hospitals. For the whole group, there was no survival benefit for patients treated in high-volume hospitals, with 10-year net survival rates of 76% (low-volume), 68% (medium-volume) and 68% (high-volume). However, subgroup analysis for patients with non low-grade and deep-seated tumours did reveal a benefit from treatment in a high-volume hospitals with 10-year survival rates of 54% (high-volume), 49% (low-volume) and 42% (medium-volume) and a relative risk of 1.3 (high-volume versus low-volume, p = 0.03). CONCLUSION: Centralisation of STS surgery has increased in the past decade. Surgery in a high-volume hospital improved survival of patients with non low-grade and deep-seated tumours, and therefore these patients should be referred to such a hospital.
引用
- Vos M, Blaauwgeers HGT, Ho VKY, et al. Increased survival of non low-grade and deep-seated soft tissue sarcoma after surgical management in high-volume hospitals: a nationwide study from the Netherlands. Eur J Cancer. 2019. PMID: 30776758. doi:10.1016/j.ejca.2019.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。